Document Detail


Impact of the Stent Length on Long-Term Clinical Outcomes Following Newer-Generation Drug-Eluting Stent Implantation.
MedLine Citation:
PMID:  24332246     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Stent length has been considered an important predictor of adverse events after percutaneous coronary intervention, even with the first-generation drug-eluting stents (DESs). The introduction of newer-generation DES has further reduced the rates of adverse clinical events such as restenosis, myocardial infarction, and stent thrombosis. The aim of this study was to compare the impact of stent length on the long-term clinical outcomes between first- and newer-generation DESs. The effects of stent length (≥32 vs <32 mm) on the clinical outcomes were evaluated in 8,445 patients who underwent percutaneous coronary intervention using either a first-generation DES (sirolimus- and paclitaxel-eluting stents, n = 6,334) or a newer-generation DES (everolimus- and zotarolimus-eluting stents, n = 2,111) from January 2004 to December 2009. The 3-year adverse outcomes (composite of all-cause death, nonfatal myocardial infarction, target vessel revascularization, and stent thrombosis) were compared using the inverse probability of treatment-weighted method according to the stent length. After adjustment for differences in the baseline risk factors, a stent length of ≥32 mm was significantly associated with higher cumulative rates of target vessel revascularization and stent thrombosis in the patients treated with a first-generation DES (adjusted hazard ratio 1.875, 95% confidence interval 1.531 to 2.297, p <0.001; adjusted hazard ratio 2.964, 95% confidence interval 1.270 to 6.917, p = 0.012), but it was not associated with the clinical outcomes in patients treated with a newer-generation DES. In conclusion, stent length might not be associated with long-term clinical outcomes in newer-generation DES era, whereas stent length might be associated with long-term clinical outcomes in the first-generation DESs.
Authors:
Ik Jun Choi; Yoon-Seok Koh; Sungmin Lim; Jin Jin Kim; Mineok Chang; Minkyu Kang; Byung-Hee Hwang; Chan Jun Kim; Tae-Hoon Kim; Suk Min Seo; Dong Il Shin; Mahn Won Park; Yun-Seok Choi; Hun-Jun Park; Sung-Ho Her; Dong-Bin Kim; Pum-Joon Kim; Jong Min Lee; Chul Soo Park; Keon Woong Moon; Kiyuk Chang; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Wook-Sung Chung; Ki-Bae Seung
Related Documents :
15875566 - Handedness, homicide and negative frequency-dependent selection.
15063436 - The prognostic significance of exercise-induced atrial arrhythmias.
19659616 - Catheter ablation versus standard conventional treatment in patients with left ventricu...
18086696 - Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recu...
3534856 - Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril trea...
23875026 - Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postcondit...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-9
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In-Hospital Arrhythmia Development and Outcomes in Pediatric Patients With Acute Myocarditis.
Next Document:  Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibr...